Literature DB >> 17690071

Neuropsychological symptoms of juvenile-onset batten disease: experiences from 2 studies.

Heather R Adams1, Jennifer Kwon, Frederick J Marshall, Elisabeth A de Blieck, David A Pearce, Jonathan W Mink.   

Abstract

Juvenile neuronal ceroid lipofuscinosis (Batten disease) is a progressive and fatal autosomal-recessive inherited lysosomal storage disorder of childhood. Core symptoms include vision loss, seizures, and mental and motor decline. This article presents data from 2 studies of neuropsychological function in juvenile neuronal ceroid lipofuscinosis. In the first cross-sectional pilot study, 15 children with genetic or clinicopathologic confirmation of juvenile neuronal ceroid lipofuscinosis completed a brief test of attention (mean age = 14.3 +/- 2.9 years, range = 8.75-18.74 years; 7 males, 8 females). Average attention performances were significantly below age-expected normative data. A second longitudinal study was then initiated to study neuropsychological function in greater depth, including change in function over time. The authors have enrolled 18 children to date (mean age = 12.88 +/- 3.59 years, range = 6.26-18.65; 11 males, 7 females). Of these, 5 children have completed a second (annual) re-evaluation. Results thus far indicate significant impairment in domains of auditory attention, memory, estimated verbal intellectual function, and verbal fluency. Neuropsychological impairment was significantly correlated with disease duration and with motor function as assessed by a disease-specific clinical neurologic rating scale. There was no significant difference between males and females in neuropsychological test performance. Neuropsychological function was worse among children with a positive seizure history. Juvenile neuronal ceroid lipofuscinosis-affected children exhibited significant and pervasive impairments on tests of auditory attention, verbal memory and repetition, verbal fluency, and an estimate of verbal intellectual ability. Preliminary follow-up data from an annual reassessment showed progressive declines in cognitive function, in particular on a task of working memory. Neuropsychological deficits are pervasive and progressive. Future research will focus on clarifying the relationship among disease duration, motor function, and neuropsychological performances, including the relative sensitivity of neuropsychological testing at different stages of motor impairment or disease duration.

Entities:  

Mesh:

Year:  2007        PMID: 17690071      PMCID: PMC3474599          DOI: 10.1177/0883073807302603

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  16 in total

Review 1.  Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III.

Authors:  W Krivit; C Peters; E G Shapiro
Journal:  Curr Opin Neurol       Date:  1999-04       Impact factor: 5.710

2.  Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten disease.

Authors:  Paul G Rothberg; Denia Ramirez-Montealegre; Sharon D Frazier; David A Pearce
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

3.  A clinical rating scale for Batten disease: reliable and relevant for clinical trials.

Authors:  F J Marshall; E A de Blieck; J W Mink; L Dure; H Adams; S Messing; P G Rothberg; E Levy; T McDonough; J DeYoung; M Wang; D Ramirez-Montealegre; J M Kwon; D A Pearce
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

4.  Lamotrigine therapy in juvenile neuronal ceroid lipofuscinosis.

Authors:  L Aberg; E Kirveskari; P Santavuori
Journal:  Epilepsia       Date:  1999-06       Impact factor: 5.864

5.  Thirty years of Batten disease research: present status and future goals.

Authors:  J A Rider; D L Rider
Journal:  Mol Genet Metab       Date:  1999-04       Impact factor: 4.797

6.  Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis.

Authors:  M L Bäckman; P R Santavuori; L E Aberg; E T Aronen
Journal:  J Intellect Disabil Res       Date:  2005-01

7.  Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis.

Authors:  S Lamminranta; L E Aberg; T Autti; R Moren; T Laine; J Kaukoranta; P Santavuori
Journal:  J Intellect Disabil Res       Date:  2001-02

8.  Standardized assessment of behavior and adaptive living skills in juvenile neuronal ceroid lipofuscinosis.

Authors:  Heather Adams; Elisabeth A de Blieck; Jonathan W Mink; Frederick J Marshall; Jennifer Kwon; Leon Dure; Paul G Rothberg; Denia Ramirez-Montealegre; David A Pearce
Journal:  Dev Med Child Neurol       Date:  2006-04       Impact factor: 5.449

9.  Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.

Authors:  C Peters; M Balthazor; E G Shapiro; R J King; C Kollman; J D Hegland; J Henslee-Downey; M E Trigg; M J Cowan; J Sanders; N Bunin; H Weinstein; C Lenarsky; P Falk; R Harris; T Bowen; T E Williams; G H Grayson; P Warkentin; L Sender; V A Cool; M Crittenden; S Packman; P Kaplan; L A Lockman; J Anderson; W Krivit; K Dusenbery; J Wagner
Journal:  Blood       Date:  1996-06-01       Impact factor: 22.113

Review 10.  CLN3, the protein associated with batten disease: structure, function and localization.

Authors:  Seasson N Phillips; Jared W Benedict; Jill M Weimer; David A Pearce
Journal:  J Neurosci Res       Date:  2005-03-01       Impact factor: 4.433

View more
  15 in total

1.  Females experience a more severe disease course in Batten disease.

Authors:  Jennifer Cialone; Heather Adams; Erika F Augustine; Frederick J Marshall; Jennifer M Kwon; Nicole Newhouse; Amy Vierhile; Erika Levy; Leon S Dure; Katherine R Rose; Denia Ramirez-Montealegre; Elisabeth A de Blieck; Jonathan W Mink
Journal:  J Inherit Metab Dis       Date:  2011-12-14       Impact factor: 4.982

2.  Quantitative telemedicine ratings in Batten disease: implications for rare disease research.

Authors:  J Cialone; E F Augustine; N Newhouse; A Vierhile; F J Marshall; J W Mink
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

Review 3.  Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  Heather R Adams; Jonathan W Mink
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

4.  Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  Heather R Adams; Christopher A Beck; Erika Levy; Rachel Jordan; Jennifer M Kwon; Frederick J Marshall; Amy Vierhile; Erika F Augustine; Elisabeth A de Blieck; David A Pearce; Jonathan W Mink
Journal:  Dev Med Child Neurol       Date:  2010-02-19       Impact factor: 5.449

Review 5.  Overview of advances in educational and social supports for young persons with NCL disorders.

Authors:  Bengt Elmerskog; Anne-Grethe Tøssebro; Rebecca Atkinson; Svein Rokne; Barbara Cole; Adam Ockelford; Heather R Adams
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-05-30       Impact factor: 5.187

6.  Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.

Authors:  Elisabeth A de Blieck; Erika F Augustine; Frederick J Marshall; Heather Adams; Jennifer Cialone; Leon Dure; Jennifer M Kwon; Nicole Newhouse; Katherine Rose; Paul G Rothberg; Amy Vierhile; Jonathan W Mink
Journal:  Contemp Clin Trials       Date:  2013-04-26       Impact factor: 2.226

Review 7.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

8.  Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system.

Authors:  John F Staropoli; Larissa Haliw; Sunita Biswas; Lillian Garrett; Sabine M Hölter; Lore Becker; Sergej Skosyrski; Patricia Da Silva-Buttkus; Julia Calzada-Wack; Frauke Neff; Birgit Rathkolb; Jan Rozman; Anja Schrewe; Thure Adler; Oliver Puk; Minxuan Sun; Jack Favor; Ildikó Racz; Raffi Bekeredjian; Dirk H Busch; Jochen Graw; Martin Klingenspor; Thomas Klopstock; Eckhard Wolf; Wolfgang Wurst; Andreas Zimmer; Edith Lopez; Hayat Harati; Eric Hill; Daniela S Krause; Jolene Guide; Ella Dragileva; Evan Gale; Vanessa C Wheeler; Rose-Mary Boustany; Diane E Brown; Sylvie Breton; Klaus Ruether; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Susan L Cotman
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

9.  Characterizing upper limb function in the context of activities of daily living in CLN3 disease.

Authors:  Hanna Hildenbrand; Jordan Wickstrom; Rebecca Parks; Cris Zampieri; Thuy-Tien Nguyen; Audrey Thurm; Kisha Jenkins; Katharine E Alter; Jesse Matsubara; Dylan Hammond; Ariane Soldatos; Forbes D Porter; An N Dang Do
Journal:  Am J Med Genet A       Date:  2021-02-08       Impact factor: 2.578

Review 10.  Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights.

Authors:  John R Ostergaard
Journal:  Degener Neurol Neuromuscul Dis       Date:  2016-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.